Malaria is one of the world’s leading killers, claiming the lives of over 250,000 children in Africa every year. Researchers have been trying for decades to come up with a viable solution to this global health problem, but haven’t made much progress. That is, until recently. This week, the world’s first malaria vaccine has begun a wide rollout, commencing in Malawi before being introduced into Ghana and Kenya over the following weeks. The RTS/S vaccine, currently the most advanced malaria vaccine in development, works by training the immune system to attack the malaria parasite, which is spread by mosquitos. The vaccine has been shown to prevent nearly 40 percent of malaria cases. While this isn’t an extraordinarily efficacious rate for a vaccine, it could still save thousands of lives in affected African areas. This initial pilot program is estimated to run until 2024, after which the results will be evaluated and broader implementation in other countries will be considered.
Pioneering malaria vaccine to roll out in Malawi
More of Today's Solutions
Roadside milkweed is giving monarchs a new migration highway
BY THE OPTIMIST DAILY EDITORIAL TEAM Researchers have planted 9,000 milkweed plants along roads in six North Florida counties, with 6,000 more going in ...
Read MoreThe physics of what happens when you suppress a sneeze
BY THE OPTIMIST DAILY EDITORIAL TEAM Holding in a sneeze carries more risk than most people assume. The injuries it can cause include ruptured ...
Read MoreHunger stones, dino tracks, and lost cities; discoveries exposed by drought
The severe droughts that are plaguing many parts of the world are altering life as we know it. Even though the climate crisis and ...
Read MoreRevolutionizing roadway power: Detroit pioneers wireless EV charging
Detroit proudly reveals the nation's trailblazing innovation: a length of road that wirelessly charges electric vehicles (EVs) on the move or at rest, signaling ...
Read More
